EIN 77-0720482

California Biotechnology Foundation

IRS 501(c) type
501(c)(3)
Num. employees
0
Year formed
2008
Most recent tax filings
2022-12-01
Description
The California Biotechnology Foundation educates the public about biotechnology and healthcare-related fields, while highlighting life science industry's efforts in combating COVID-19 and other illnesses. CBF continues to publish weekly COVID-19 update newsletter in 2022 with emerging news and pertinent information related to life science advancements in testing, treatments, etc.
Total revenues
$872,550
2022
Total expenses
$899,739
2022
Total assets
$40,661
2022
Num. employees
0
2022

Program areas at California Biotechnology Foundation

Highlight life science industrys efforts on combating COVID-19 and other illnesses*CBF continued publishing weekly COVID-19 update newsletter in 2022 with emerging news and pertinent information related to life science advancements in testing, treatments, and vaccines.*CBF used social media, the website, and digital advertising to share updates on the emerging MPox public health challenge. Materials included highlights of efforts to prevent MPox from reaching pandemic status. These efforts were highlighted in CBFs monthly newsletter.*Developed COVID-19 timeline fact sheet on vaccines, tests, treatments for monthly newsletter.Other Education *Overview of life sciences in California to policymakers at a briefing.*Engaged policymakers through regular email updates, newsletter content and social media. *Position CBF as the Go-To Informational Resource to learn more about CA Life Sciences *Event Tour of WA Life Sciences with Industry RepresentativesCollateral: Facts Sheets, Updates, and Newsletters*COVID-19 Timeline of Life Science Medical Innovations Fact Sheet: steps taken to combat the COVID-19 pandemic and dispel misinformation related to vaccine development and deployment.*Life Science Innovations Fight COVID-19 Fact Sheet: CAs role in developing approaches to testing, clinical trials, vaccines, and treatments.*JAMA Study Examines Whether 340B Drug Discount Program Genuinely Serves Vulnerable Communities Fact Sheet: developed in response to a JAMA study showing that 340B benefits primarily served white, affluent areas.*DMHC Report Shows Health Plan Profit and Non-Medical Expenses Far Exceed Rx Expenditures Fact Sheet: DMHC reports on prescription drug consumer expenditures.Maintain stakeholder relationships*Biocom 2021 Economic Impact Report Databook information*Regularly attendance at a variety of stakeholder meetings*Highlight stakeholders at events, and in newsletters and social media *Amplify the latest stakeholder news and events Execute social media campaign to leverage facts around life sciences in CA*Designed and executed multiple social media and digital display campaigns to educate stakeholders.*Strategically deployed digital to support priority activities of the team to bring historically offline activities into a digital environment. *CBF maintains a robust organic social media presence including sharing the latest news and events from stakeholder and highlighting healthcare stakeholders on social media during awareness months such as Hispanic Heritage Month and Breast Cancer Awareness Month.

Who funds California Biotechnology Foundation

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Pharmaceutical Research and Manufacturers of of America (PHRMA)General Contribution$120,000

Personnel at California Biotechnology Foundation

NameTitleCompensation
Patricia CooperExecutive Director$169,180
Amanda BanksSecretary$0
Joseph PanettaChairman$0
Joe PanettaBoard Member$0

Financials for California Biotechnology Foundation

RevenuesFYE 12/2022
Total grants, contributions, etc.$872,550
Program services$0
Investment income and dividends$0
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$872,550

Form 990s for California Biotechnology Foundation

Fiscal year endingDate received by IRSFormPDF link
2022-122023-05-16990View PDF
2021-122022-11-10990View PDF
2020-122021-09-03990View PDF
2019-122021-02-24990View PDF
2018-122019-06-19990View PDF
...and 10 more Form 990s
Data update history
July 20, 2023
Posted financials
Added Form 990 for fiscal year 2022
July 15, 2023
Posted financials
Added Form 990 for fiscal year 2021
May 22, 2023
Received grants
Identified 1 new grant, including a grant for $120,000 from Pharmaceutical Research and Manufacturers of America (PhRMA)
June 25, 2022
Posted financials
Added Form 990 for fiscal year 2020
October 2, 2021
Received grants
Identified 1 new grant, including a grant for $30,000 from Pharmaceutical Research and Manufacturers of America (PhRMA)
Nonprofit Types
Grantmaking organizationsResearch centersCharities
Issues
Science and technology
Characteristics
MembershipsConducts researchState / local levelTax deductible donationsNo full-time employeesAccepts online donations
General information
Address
1215 K St 970
Sacramento, CA 95814
Metro area
Sacramento-Roseville-Folsom, CA
County
Sacramento County, CA
Website URL
cabiotech.org/ 
Phone
(916) 233-3499
IRS details
EIN
77-0720482
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2008
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
U50: Biological, Life Science Research
NAICS code, primary
813211: Grantmaking Foundations
Parent/child status
Independent
Free account sign-up

Want updates when California Biotechnology Foundation has new information, or want to find more organizations like California Biotechnology Foundation?

Create free Cause IQ account